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with patients randomized to placebo (3.8 years (95% CI: 3.3–4.2) for
BQ-123 versus 2.8 years (2.1-3.4) for placebo, p = 0.032, Figure 1).
Conclusion: Short-term administration of BQ-123 in patients undergo-
ing primary PCI for STE-ACS leads to a longer cardiovascular event-free
survival.
doi:10.1016/j.lfs.2014.01.034
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Introduction: Little has been known about clinical background of
the patients with heart failure (HF) and sleep disordered breathing
(SDB). The aim of this study was to elucidate the relationship
between HF and SDB. Methods: 1121 patients admitted to our
institute with the diagnosis of HF between 2006 and 2012 was
enrolled. SDB was deﬁned N5/h of apnea–hypopnea index (AHI).
Obstructive sleep apnea (OSA) group and central sleep apnea (CSA)
group were deﬁned based on the data of type III sleep monitor
(Morpheus). Results: Among 1121 patients 328 (29%) underwent
screening of type III sleep monitor. In the 328 patients, 275 (84%)
patients showed SDB. Among these 275 SDB patients, 135 (41%)
were OSA, and 140 (43%) were CSA. AHI was signiﬁcantly higher
(OSA: 22.5 ± 16.2, CSA: 29.8 ± 14.9, P b 0.05) and ejection fraction
(EF) was signiﬁcantly lower (OSA: 40.1 ± 17.1%, CSA: 33.5 ± 14.1%,
P b 0.05) in CSA group between two groups. Among 140 CSA
patients, 80 (57%) patients have heart failure with reduced ejection
fraction (HFREF) and among 135 OSA patients, 60 (44%) patients
have HFREF. Conclusions: SDB was highly associated with HF and the
clinical features between OSA and CSA with HF were different. CSA
patients were associated with lower EF and higher AHI than OSA
patients. This study suggested that SDB was one of an important
target of treatment HF and to treat HF according to these clinical
subsets of SDB was clinically required in the future.
doi:10.1016/j.lfs.2014.01.035
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Pharmacological inhibition and genetic deletion (Murakoshi et al.,
2002; Kirkby et al., 2012) suggest that endothelin (ET) A-selective
antagonists are preferable to mixed ETA/B antagonists for prevention of
neointimal lesion formation. ETB receptors expressed in smoothmuscle
cells may, however, contribute to lesion development. It was proposed
that ETB deletion from smooth muscle (SM) would reduce lesion
formation following arterial injury. Methods: Mice bearing a ﬂoxed ETB
gene or expressing cre-recombinase under the SM22 promoter were
crossed to produce SM-selective ETB deletion. SMETB knockout mice
were identiﬁed by genotyping and backcrossed to C57Bl/6J (4–6
generations). Functional conﬁrmation of ET deletion was determined
by exposing trachea, and mesenteric artery and vein, to sarafotoxin 6c
in a myograph. Femoral injury was performed in adult, male SMETB
knockout mice and littermate controls and arteries were harvested
33 days later for structural analysis. Results: SMETB knockout reduced
(~55%), but did not abolish, ETB-mediated contraction in trachea. In
contrast, S6c-mediated contraction in mesenteric veins (130+ 46%
KPSS, n = 4), and in mesenteric arteries cultured for 24 h (72 + 24%
KPSS, n = 4), was abolished by SMETB deletion (5.1 + 3.4% KPSS and
0% KPSS, respectively). Femoral artery injury produced large, neointi-
mal lesions (47.4 + 10.6%; n = 7) but SMETB knockout did not alter
lesion size (42.2 + 4.5%; n = 9; P = 0.64). Conclusions: Stimulation of
ETB receptors in SM does not inﬂuence neointimal lesion formation.
This supports the suggestion that ETA-selective antagonists are
preferable to non-selective antagonists for prevention of neointimal
proliferation. The study was funded by the BHF (project grant and
CoRE). Murakoshi et al. (2002) Circulation 106:15; Kirkby et al. (2012)
Cardiovasc Res, 95, 19.
doi:10.1016/j.lfs.2014.01.036
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Incubation of arteries ex vivo induces ETB-mediated contraction
(Adner et al., 1998), possibly via transcriptional mechanisms (Skovsted
et al., 2012). ETB receptors are also expressed in neointimal lesions
(Azuma et al., 1994). It was proposed that ETB-mediated contraction
would be induced by neointimal lesion formation. Methods: Femoral
arteries from adult, male C57Bl/6J mice (n= 6) were harvested 36 +/
− 2 days after ligation. Isolated mesenteric and femoral veins and
arteries from uninjured mice were cultured (DMEM; 37 °C; 5% CO2;
5 days) before analysis in a myograph. Contractile function was as-
sessed using phenylephrine (10−9–3 × 10-5 M), endothelin-1 (10−11–
10−7M) and sarafotoxin 6c (10−11–10−7M). Relaxant function
was assessed using endothelium-dependent (acetylcholine; 10−9–3 ×
10−5 M) and independent (sodium nitroprusside; 10−9–3 × 10−5M)
agents after contraction with phenylephrine. Results: Freshly isolated
mesenteric veins contracted in response to S6c whereas mesenteric
arteries and femoral veins did not. Some (4/10) femoral arteries
produced small S6c-induced contractions (21.86 +/− 3.72% KPSS,
Abstractse70
n= 4). Incubation induced ETB-mediated contraction in mesenteric,
but not in femoral arteries. Arterial ligation had little effect on
contractile or relaxant function of murine femoral arteries and did not
induce a contractile response to S6c. Conclusions: Neointimal lesion
formation did not induce S6c-mediated contraction in mouse femoral
arteries, possibly because ETB receptor activity cannot be induced in
this artery. These data do not support the need for mixed ETA/ETB
antagonists for inhibition of neointimal lesion formation. The studywas
supported by the BHF (project grant and CoRE). Adner et al. (1998) Acta
Physiol Scand, 163,121; Azuma et al. (1994) Am J Physiol, 267, H2259;
Skovsted et al. (2012) Life Sci, 91, 593.
doi:10.1016/j.lfs.2014.01.037
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The role of vascular smooth muscle endothelin A receptors (ETA) in
development and normal physiology remains incompletely under-
stood. To address this, mice were generated with smooth muscle-
speciﬁc knockout (KO) of ETA. Mice were homozygous for loxP-ﬂanked
exons 6–8 of the ETA gene (ﬂoxed) or were also hemizygous for a
transgene expressing Cre recombinase under control of the smooth
muscle-speciﬁc SM22 promoter (KO mice). Genotyping at 17 days
postnatal yielded a 5:1 ratio of ﬂoxed: KO mice. Smooth muscle actin
staining of embryos at day E9.5 revealed increased tortuosity in dorsal
aortae. Mice surviving to weaning developed and bred normally. ETA
KOmice aged 2–3monthsmanifested EDNRA gene recombination in all
organs tested. Aortas from KOmice had a N90% reduction in ETAmRNA
content, but no differences between genotypes in ET-1 or ETB mRNA
levels. The addition of 0.01–100 nM ET-1 to isolated femoral arteries
from ﬂoxed, but not KO, mice dose-dependently decreased vessel
diameter (up to 80% reduction in the presence of ETB blockade).
Intravenous infusion of ET-1 into ﬂoxed, but not KO, mice acutely
increased mean arterial pressure (MAP) (by ~10 mm Hg). Telemetric
analysis revealed decreased MAP in KO mice (by ~7–10 mmHg); this
MAP reductionwas evident on normal and high salt diets. In conclusion,
ETA is important for vascular development and is involved in the
maintenance of arterial pressure under physiological conditions.
doi:10.1016/j.lfs.2014.01.038
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Background: Endothelin-1 (ET-1) is a potent vasoconstrictor and
an elevated plasma level is a prognostic marker in patients with
cardiovascular diseases and/or malignancies. We hypothesized that
an elevated plasma level might be a prognostic marker even in
subjects without apparent cardiovascular disease or malignancy at
baseline. Methods and results: We measured plasma ET-1 levels in
1440 healthy subjects over 40 years of age (580 men, 860 women) who
were periodically followed for 10 years. The follow-up rate was 96.8%.
Baseline plasma ET-1 levels were categorized into quartiles. Baseline
plasma ET-1 levelswere signiﬁcantly associatedwith age, blood pressure,
high-density lipoprotein-cholesterol, renal function, uric acid and all-
cause death, but not with cardiovascular or cancer death. Kaplan–Meier
curves demonstrated that all-cause mortality was signiﬁcantly higher in
the highest quartile of ET-1 than in the lowest quartile. Cox proportional
hazards regression analysis demonstrated that ET-1 was an independent
predictor of all-cause death [hazard ratio: 1.11, 95% conﬁdence interval
(CI) 1.01–1.23 per 1 pg/ml difference]. The hazard ratio of all-cause death
in the highest quartile of plasma ET-1 (N5.9 pg/ml) vs. the lowest quartile
after adjusting for confounding factors was 1.54 (95% CI 1.09–2.20).
Conclusions: The plasma ET-1 level may be a predictor of all-cause death
in a healthy population.
doi:10.1016/j.lfs.2014.01.039
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Background: Metabolic alterations and endothelial dysfunction are
interrelated processes in type 2 diabetes andmetabolic syndrome (MetS)
that often develop in parallel. In this study we assessed the association of
vasoactive peptide, endothelin-1 (ET-1) with MetS conducted in a study
in rural Bangladeshi women. Design and methods: Plasma level of ET-1
wasmeasured by ELIZA andMetSwas deﬁned according to the criteria of
NCEP-ATP III. Logistic regression was used to examine the associa-
tion between circulatory ET-1 level and MetS and its components.
Results: A total of 1485 rural Bangladeshi women aged N15 years were
studied using a population based cross-sectional survey. The prevalence
rate of MetS was 25.05% (NCEP ATP III). Mean values of BMI, waist
circumference, blood pressure (SBP, DBP), plasma level of fasting glucose,
triglyceride, HDL, cholesterol, insulin and vascular endothelial growth
factor were signiﬁcantly higher in MetS group compared to non-MetS
group. ET-1 levels were signiﬁcantly increased inMetS subjects (MetS vs.
non-MetS: 4.32 ± 0.24 vs. 3.41 ± 0.18, p = 0.003). In multivariable
analyses, we found that ET-1 had signiﬁcant positive associations with
DBP (beta = 0.051, p = 0.001) and SBP (beta = 0.028, p b 0.001)
even after adjusting for age. We also found that mean plasma levels of
ET-1 increased in direct proportion to levels of MetS components.
Conclusions: We here demonstrate for the ﬁrst time that in Bangladeshi
rural women, plasma level of ET-1 is related toMetS and its components,
suggesting a possible role of ET-1 as a surrogate biomarker for the disease
and its complications. This is the ﬁrst study assessing ET-1 in Mets
subjects from a South Asian country.
doi:10.1016/j.lfs.2014.01.040
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